Literature DB >> 29956545

TCFH-NMI: Direct Access to N-Acyl Imidazoliums for Challenging Amide Bond Formations.

Gregory L Beutner1, Ian S Young1, Merrill L Davies1, Matthew R Hickey1, Hyunsoo Park1, Jason M Stevens1, Qingmei Ye1.   

Abstract

Challenging couplings of hindered carboxylic acids with non-nucleophilic amines to form amide bonds can be accomplished in high yields, and in many cases, with complete retention of the adjacent stereogenic centers using the combination of N, N, N', N'-tetramethylchloroformamidinium hexafluorophosphate (TCFH) and N-methylimidazole (NMI). This method allows for in situ generation of highly reactive acyl imidazolium ions, which have been demonstrated to be intermediates in the reaction. The reagent delivers high reactivity similar to acid chlorides with the ease of use of modern uronium reagents.

Entities:  

Year:  2018        PMID: 29956545     DOI: 10.1021/acs.orglett.8b01591

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.

Authors:  Elaine A Gay; Dongliang Guan; Kalynn Van Voorhies; Vineetha Vasukuttan; Kelly M Mathews; Joyce Besheer; Chunyang Jin
Journal:  J Med Chem       Date:  2022-05-20       Impact factor: 8.039

2.  The Design and Synthesis of a New Series of 1,2,3-Triazole-Cored Structures Tethering Aryl Urea and Their Highly Selective Cytotoxicity toward HepG2.

Authors:  Sittisak Oekchuae; Jitnapa Sirirak; Purin Charoensuksai; Pawaris Wongprayoon; Natthaya Chuaypen; Jutatip Boonsombat; Somsak Ruchirawat; Pisit Tangkijvanich; Apichart Suksamrarn; Panupun Limpachayaporn
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-20

3.  Macrocyclization of bis-indole quinolines for selective stabilization of G-quadruplex DNA structures.

Authors:  Rabindra Nath Das; Måns Andréasson; Rajendra Kumar; Erik Chorell
Journal:  Chem Sci       Date:  2020-09-16       Impact factor: 9.825

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.